BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 7786770)

  • 21. Induction chemotherapy versus palliative treatment for acute myeloid leukemia in a consecutive cohort of elderly patients.
    Colovic M; Colovic N; Radojkovic M; Stanisavljevic D; Kraguljac N; Jankovic G; Tomin D; Suvajdzic N; Vidovic A; Atkinson HD
    Ann Hematol; 2012 Sep; 91(9):1363-70. PubMed ID: 22592651
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differences in prognostic factors between leukemia and lymphoma type of adult T-cell leukemia.
    Shimamoto Y; Ono K; Sano M; Matsuzaki M; Suga K; Sueoka E; Tokioka T; Yamaguchi M; Suzuki H; Sato H
    Cancer; 1989 Jan; 63(2):289-94. PubMed ID: 2910433
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum deoxythymidine kinase in small cell carcinoma of the lung. Relation to clinical features, prognosis, and other biochemical markers.
    Gronowitz JS; Steinholtz L; Källander CF; Hagberg H; Bergh J
    Cancer; 1986 Jul; 58(1):111-8. PubMed ID: 3011236
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of fos proto-oncogene product by monoclonal antibody FO-120 in smouldering adult T-cell leukaemia (ATL).
    Iwahashi M; Otsuka M; Shimotakahara S; Uozumi K; Hanada S; Arima T; Matsumoto M
    Br J Haematol; 1994 Jan; 86(1):193-4. PubMed ID: 8011529
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum beta 2-microglobulin in patients with adult T-cell leukemia.
    Tsuda H; Ishii T; Sawada T; Takatsuki K
    Acta Haematol; 1991; 86(1):31-5. PubMed ID: 1950359
    [TBL] [Abstract][Full Text] [Related]  

  • 26. GM-CSF raises serum levels of beta 2-microglobulin and thymidine kinase in patients with chronic lymphocytic leukaemia.
    Itälä M; Pelliniemi TT; Remes K
    Br J Haematol; 1996 Jul; 94(1):129-32. PubMed ID: 8757522
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Acute myeloid leukemia in those over 70 years of age. Experience using low-dose ara-C treatment].
    Rodríguez JN; Fernández-Jurado A; Martino ML; Diéguez JC; Moreno MV; Quesada JA; Polo B; Cañavate M; Amian A; Prados D
    Sangre (Barc); 1998 Feb; 43(1):35-9. PubMed ID: 9580427
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Two cases of secondary acute myeloid leukemia accompanying adult T-cell leukemia/lymphoma.
    Owatari S; Otsuka M; Uozumi K; Takeshita T; Hanada S
    Int J Hematol; 2007 Jan; 85(1):32-5. PubMed ID: 17261499
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vascular endothelial growth factor secretion is an independent prognostic factor for relapse-free survival in pediatric acute myeloid leukemia patients.
    de Bont ES; Fidler V; Meeuwsen T; Scherpen F; Hählen K; Kamps WA
    Clin Cancer Res; 2002 Sep; 8(9):2856-61. PubMed ID: 12231527
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thymidine kinase 1--a prognostic and diagnostic indicator in ALL and AML patients.
    O'Neill KL; Zhang F; Li H; Fuja DG; Murray BK
    Leukemia; 2007 Mar; 21(3):560-3. PubMed ID: 17252017
    [No Abstract]   [Full Text] [Related]  

  • 31. Adult T-cell leukaemia/lymphoma can mimic other lymphomas in a non-endemic area: dilemmas in diagnosis and treatment.
    Huang CT; Lee YH; Chow KC; Yang CF; Chen PC; Hsiao LT; Gau JP; Tzeng CH; Liu CY; Chiou TJ
    Intern Med J; 2014 Apr; 44(4):374-83. PubMed ID: 24533861
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum beta(2)-microglobulin and serum thymidine kinase are independent predictors of progression-free survival in chronic lymphocytic leukemia and immunocytoma.
    Hallek M; Wanders L; Ostwald M; Busch R; Senekowitsch R; Stern S; Schick HD; Kuhn-Hallek I; Emmerich B
    Leuk Lymphoma; 1996 Aug; 22(5-6):439-47. PubMed ID: 8882957
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment for adult T-cell leukemia.
    Hanada S; Utsunomiya A; Suzuki S; Uozumi K; Makino T; Arima T
    Cancer Chemother Pharmacol; 1997; 40 Suppl():S47-50. PubMed ID: 9272134
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combined analysis of differentiation inhibitory factor nm23-H1 and nm23-H2 as prognostic factors in acute myeloid leukaemia.
    Wakimoto N; Yokoyama A; Okabe-Kado J; Nagata N; Motoyoshi K; Honma Y
    Br J Cancer; 1998 Jun; 77(12):2298-303. PubMed ID: 9649149
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased risk of neurological relapse in acute lymphoblastic leukemias with high levels of cerebrospinal fluid thymidine kinase at diagnosis.
    Musto P; Modoni S; Ladogana S; Salcuni G; Fusilli S; Carotenuto M
    Leuk Lymphoma; 1993 Jan; 9(1-2):121-4. PubMed ID: 8477191
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro efficacy of l-asparaginase in childhood acute myeloid leukaemia.
    Okada S; Hongo T; Yamada S; Watanabe C; Fujii Y; Ohzeki T; Horikoshi Y; Ito T; Yazaki M; Komada Y; Tawa A
    Br J Haematol; 2003 Dec; 123(5):802-9. PubMed ID: 14632770
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quantification and cytokine production of circulating lymphoid and myeloid cells in acute myelogenous leukaemia.
    Panoskaltsis N; Reid CD; Knight SC
    Leukemia; 2003 Apr; 17(4):716-30. PubMed ID: 12682629
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Biological properties and sensitivity to induction therapy of differentiated cells expressing atypical immunophenotype in acute leukemia of children].
    Pituch-Noworolska A
    Folia Med Cracov; 2001; 42(3):5-80. PubMed ID: 12353422
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma. A report from the Lymphoma Study Group (1984-87).
    Shimoyama M
    Br J Haematol; 1991 Nov; 79(3):428-37. PubMed ID: 1751370
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acute myeloid leukemia-FAB classification and its correlation with clinico-haematological features.
    Hassan K; Qureshi M; Shafi S; Ikram N; Akhtar MJ
    J Pak Med Assoc; 1993 Oct; 43(10):200-3. PubMed ID: 8114248
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.